Article
Comparison of the time-to-response between radiotherapy and epidermal growth factor receptor--tyrosine kinase inhibitors for advanced non-small cell lung cancer with EGFR mutation.
Anticancer research - 1 Aug 2013
Imai Hisao, Shukuya Takehito, Takahashi Toshiaki, Fujiwara Sakae, Mori Keita, Ono Akira, Akamatsu Hiroaki, Taira Tetsuhiko, Kenmotsu Hirotsugu, Naito Tateaki, Kaira Kyoichi, Murakami Haruyasu, Harada Hideyuki, Endo Masahiro, Nakajima Takashi, Yamamoto Nobuyuki
Abstract excerpt
BACKGROUND: Patients harboring sensitive epidermal growth factor receptor (EGFR) mutations show a dramatic response to treatment with EGFR tyrosine kinase inhibitors (TKIs). However, there have been no clinical reports in lung cancer patients that compare the time-to-response between radiotherapy...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.